title: New trends in diagnosis and treatment of chronic intestinal strongyloidiasis stercoralis in Egyptian patients.
abstract: Strongyloidiasis, caused by Strongyloides stercoralis, is diagnosis considered as a challenge to clinician and laboratory technician. Because the auto-infective larvae are difficult to eradicate, one regimen dose may be in-sufficient and re-treatment of patients on two occasions, at 1 and 2 months after the initial treatment dose was recommended. This re-treatment regimen has yet to be proven in clinical trials. This study was performed on 24 patients who completed the study and having Strongyloides larvae in their stool obtained from Mansoura University Hospitals. Each stool sample was examined by direct saline smear, the formalin-ether sedimentation technique and agar plate culture. Patients were treated with Mirazid double course for a month to be followed up by stool examination by traditional method and agar plate culture for three consecutive months. In this study five cases out of 24 were asymptomatic (20.8%). Symptoms include abdominal manifestations as nausea and vomiting (16.7%), epi-gastric pain and nausea (12.5%), generalized abdominal pain (12.5%), chronic diarrhea (16.7%), irregular bowel habit (8.3%), and urticaria with abdominal pain (4.2%). Agar plate culture gave 100% positivity, even in cases were negative by coprological methods either direct smear and/or sedimenttation technique. All cases were cured by Mirazid given for one month except three resistant cases. Only one case responded to repeated course of Mirazid, while the other two cases still had larvae in their stool by agar culture plate. On combined therapy of both Mirazid and Mebendazole, larvae could be eliminated from their stool as approved by agar plate culture.
authors.affiliation: Department of Tropical Medicine, Faculty of Medicine, Al-Azhar University, Cairo.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Massoud
authors.forename: Atef M
authors.initials: AM
authors.lastname: El-Shazly
authors.forename: Soha E
authors.initials: SE
authors.lastname: Awad
authors.forename: Ayman T A
authors.initials: AT
authors.lastname: Morsy
authors.forename: Gehan S
authors.initials: GS
authors.lastname: Sadek
authors.forename: Tosson A
authors.initials: TA
authors.lastname: Morsy
mesh_terms: D000293:Adolescent; D000328:Adult; D000362:Agar; D000368:Aged; D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D004351:Drug Resistance; D005243:Feces / Q000469:parasitology; D006801:Humans; D007411:Intestinal Diseases, Parasitic / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010270:Parasite Egg Count; D017171:Strongyloides stercoralis / Q000187:drug effects / Q000302:isolation & purification; D013322:Strongyloidiasis / Q000175:diagnosis* / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000871:Anthelmintics; D000362:Agar